Robert Judd

Dr. Robert Judd


Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 January 2011
Verified
Book Chapter
Open access
PDF file
HFHan Fang
Han Fang
RJRobert Judd
Robert Judd
Adipose tissue is now recognized as an important endocrine organ, capable of secreting a large number of endocrine factors which regulate a wide variety of physiological functions. Adiponectin is one such factor, secreted in large quantities primarily from adipose tissue. Adiponectin is posttranslationally modified from a 30‐kDa monomeric protein into different multimers (low molecular weight or trimer, middle molecular weight or hexamer, and high molecular weight) and secreted into the circulation. Upon binding to its receptors, AdipoR1 and R2, adiponectin initiates a series of tissue‐dependent signal transduction events, including phosphorylation of adenosine monophosphate (AMPK) and p38 mitogen‐activated protein kinase (p38 MAPK), and increased peroxisome proliferator‐activated receptor alpha (PPARα) ligand activity. These signal transduction events are regulated by adaptor protein containing a pleckstrin homology domain, phosphotyrosine binding domain, and leucine zipper motif (APPL1), which binds directly to the intracellular regions of AdipoR1 and R2. AdipoR1 and R2 also possesses inherent ceramidase activity, resulting in a decrease in intracellular ceramide, a sphingolipid that has been implicated in insulin resistance, cell death, inflammation, and atherosclerosis. Adiponectin stimulates fatty acid oxidation in skeletal muscle and inhibits glucose production in the liver, resulting in an improvement in whole‐body energy homeostasis. Adiponectin is also a classic anti‐inflammatory agent, reducing inflammation in various cell types through AdipoR1 and R2 signaling mechanisms. Adiponectin's anti‐inflammatory and anti‐apoptotic properties results in protection of the vasculature, heart, lung, and colon. In this review, we provide a comprehensive overview of the discovery, protein structure, receptors, expression, regulation, and physiological functions of adiponectin. © 2017 American Physiological Society.Compr Physiol8:1031‐1063, 2018.

1 February 2016 in Metabolism
Verified
Journal Article
Closed access
EGEmily C. Graff
Emily C. Graff
HFHan Fang
Han Fang
DWDesiree Wanders
Desiree Wanders
RJRobert Judd
Robert Judd

13 August 2013 in PLOS ONE
Verified
Journal Article
Open access
PDF file
DWDesiree Wanders
Desiree Wanders
EGEmily C Graff
Emily C Graff
BWB Douglas White
B Douglas White
RJRobert Judd
Robert Judd
To determine the effects of niacin on adiponectin and markers of adipose tissue inflammation in a mouse model of obesity. Male C57BL/6 mice were placed on a control or high-fat diet (HFD) and were maintained on such diets for the duration of the study. After 6 weeks on the control or high fat diets, vehicle or niacin treatments were initiated and maintained for 5 weeks. Identical studies were conducted concurrently in HCA2−/− (niacin receptor−/−) mice. Niacin increased serum concentrations of the anti-inflammatory adipokine, adiponectin by 21% in HFD-fed wild-type mice, but had no effect on lean wild-type or lean or HFD-fed HCA2−/− mice. Niacin increased adiponectin gene and protein expression in the HFD-fed wild-type mice only. The increases in adiponectin serum concentrations, gene and protein expression occurred independently of changes in expression of PPARγ C/EBPα or SREBP-1c (key transcription factors known to positively regulate adiponectin gene transcription) in the adipose tissue. Further, niacin had no effect on adipose tissue expression of ERp44, Ero1-Lα, or DsbA-L (key ER chaperones involved in adiponectin production and secretion). However, niacin treatment attenuated HFD-induced increases in adipose tissue gene expression of MCP-1 and IL-1β in the wild-type HFD-fed mice. Niacin also reduced the expression of the pro-inflammatory M1 macrophage marker CD11c in HFD-fed wild-type mice. Niacin treatment attenuates obesity-induced adipose tissue inflammation through increased adiponectin and anti-inflammatory cytokine expression and reduced pro-inflammatory cytokine expression in a niacin receptor-dependent manner.

21 June 2011 in Diabetes, Obesity and Metabolism
Verified
Journal Article
Closed access
PDF file
DWDesiree Wanders
Desiree Wanders
RJRobert Judd
Robert Judd

1 January 2010 in World Journal of Diabetes
Verified
Journal Article
Open access
DWDesiree Wanders
Desiree Wanders
EPEric P Plaisance
Eric P Plaisance
RJRobert Judd
Robert Judd
Pharmacological effects of lipid-lowering drugs on circulating adipokines

23 February 2021 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
ZLZhuoyue Li
Zhuoyue Li
KMKayleen J. McCafferty
Kayleen J. McCafferty
RJRobert Judd
Robert Judd
Hydroxycarboxylic acid receptor 2 (HCA2) is vital for sensing intermediates of metabolism, including β-hydroxybutyrate and butyrate. It also regulates profound anti-inflammatory effects in various tissues, indicating that HCA2 may serve as an essential therapeutic target for mediating inflammation-associated diseases. Butyrate and niacin, endogenous and exogenous ligands of HCA2, have been reported to play an essential role in maintaining intestinal homeostasis. HCA2, predominantly expressed in diverse immune cells, is also present in intestinal epithelial cells (IECs), where it regulates the intricate communication network between diet, microbiota, and immune cells. This review summarizes the physiological role of HCA2 in intestinal homeostasis and its pathological role in intestinal inflammation and cancer.